Which ONE of the following is necessary after chimeric antigen receptor (CAR)‐T cell therapy for relapsed acute lymphoblastic leukaemia?
Select one:
A.2 years of maintenance mercaptopurine
B.2 years of maintenance mercaptopurine
C.Prophylactic antifungal therapy
D.Lifelong immunoglobulin replacement therapy
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here